Fumie Griego is a member of the Expert Review Committee for the Access to Medicine Index in 2018. She is the Assistant Director General for Strategic Planning, Policy and Research at IFPMA where she leads IFPMA’s work on health economics and policy such as value of medicines, pricing and reimbursement, and metrics/evaluation.
Prior to joining IFPMA, Fumie was Head of Global Oncology Policy and Strategy, Global Government Affairs & Policy at Merck KGaA and Vice President for International Health Policy at Pharmaceutical Research and Manufacturers of America (PhRMA). Prior to joining PhRMA, Fumie was as a senior economist in the White House’s Office of Management and Budget where she provided U.S. senior officials in both the Bush and Obama Administrations with policy advice on a range of health policy issues. Fumie holds a Doctor of Philosophy in Health Policy from Harvard University and a Bachelor and Master of Science degrees in Earth Systems (concentration in environmental economics and policy) from Stanford University.